Smsa Crane Acquisition (SSCR) 10-Q 16 Dec 19 2018 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2018	Dec. 13, 2018
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2018
Entity Registrant Name	SMSA CRANE ACQUISITION CORP.
Entity Central Index Key	0001473287
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		10,047,495
Emerging Growth Company	false
Smaller Reporting Company	true
Reporting Status	No
Entity File Number	000-53800

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Current Assets
Cash - attorney escrow account		$ 19,265
Total Current Assets		19,265
Current Liabilities
Accounts payable and accrued expenses	15,959	7,393
Due to shareholder	39,115	39,115
Total Current Liabilities	55,074	46,508
Total Liabilities	55,074	46,508
Stockholders' Deficit
Preferred stock - $0.001 par value, 10,000,000 shares authorized. No shares issued and outstanding
Common stock - $0.001 par value, 100,000,000 shares authorized. 10,047,495 shares issued and outstanding	10,048	10,048
Additional paid-in capital	341,928	341,928
Accumulated deficit	(407,050)	(379,219)
Total Stockholders' Deficit	(55,074)	(27,243)
Total Liabilities and Stockholders' Deficit		$ 19,265

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	10,047,495	10,047,495
Common stock, shares outstanding	10,047,495	10,047,495

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Revenues
Operating expenses
Professional fees	16,576	37,000	22,607	37,000
Other general and administrative expenses	4,374	5,030	5,224	5,848
Total operating expenses	20,950	42,030	27,831	42,848
Other Income (Expense)
Total Other Income (Expense)
Income (Loss) from operations	(20,950)	(42,030)	(27,831)	(42,848)
Provision for income taxes
Net Income (Loss)	$ (20,950)	$ (42,030)	$ (27,831)	$ (42,848)
Earnings (Loss) per weighted-average share of common stock outstanding, computed on net income (loss) - basic and fully diluted	$ 0	$ 0	$ 0	$ 0
Weighted-average number of shares of common stock outstanding - basic and fully diluted	10,047,495	10,644,995	10,047,495	11,151,408

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Beginning balance, value at Dec. 31, 2016	$ 11,664	$ 49,546	$ (305,557)	$ (244,347)
Beginning balance, shares at Dec. 31, 2016	11,663,448
Net loss for the period			(818)	(818)
Ending balance, value at Mar. 31, 2017	$ 11,664	49,546	(306,375)	(245,165)
Ending balance, shares at Mar. 31, 2017	11,663,448
Beginning balance, value at Dec. 31, 2016	$ 11,664	49,546	(305,557)	(244,347)
Beginning balance, shares at Dec. 31, 2016	11,663,448
Net loss for the period				(42,848)
Ending balance, value at Jun. 30, 2017	$ 10,048	288,811	(348,405)
Ending balance, shares at Jun. 30, 2017	10,047,495
Beginning balance, value at Mar. 31, 2017	$ 11,664	49,546	(306,375)	(245,165)
Beginning balance, shares at Mar. 31, 2017	11,663,448
Cancellation of shares, value	$ (1,663)	1,663
Cancellation of shares, shares	(1,643,443)
Issuance of shares for debt, value	$ 47	15,748		157,195
Issuance of shares for debt, shares	47,490
Shareholders' contribution		130,000		130,000
Net loss for the period			(42,030)	(42,030)
Ending balance, value at Jun. 30, 2017	$ 10,048	288,811	(348,405)
Ending balance, shares at Jun. 30, 2017	10,047,495
Beginning balance, value at Dec. 31, 2017	$ 10,048	341,928	(379,219)	$ (27,243)
Beginning balance, shares at Dec. 31, 2017	10,047,495			10,047,495
Net loss for the period			(68,810)	$ (6,881)
Ending balance, value at Mar. 31, 2018	$ 10,048	341,928	(386,100)	(34,124)
Ending balance, shares at Mar. 31, 2018	10,047,495
Beginning balance, value at Dec. 31, 2017	$ 10,048	341,928	(379,219)	$ (27,243)
Beginning balance, shares at Dec. 31, 2017	10,047,495			10,047,495
Net loss for the period				$ (27,831)
Ending balance, value at Jun. 30, 2018	$ 10,048	341,928	(407,050)	$ (55,074)
Ending balance, shares at Jun. 30, 2018	10,047,495			10,047,495
Beginning balance, value at Mar. 31, 2018	$ 10,048	341,928	(386,100)	$ (34,124)
Beginning balance, shares at Mar. 31, 2018	10,047,495
Net loss for the period			(20,950)	(20,950)
Ending balance, value at Jun. 30, 2018	$ 10,048	$ 341,928	$ (407,050)	$ (55,074)
Ending balance, shares at Jun. 30, 2018	10,047,495			10,047,495

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Cash Flows from Operating Activities:
Net loss for the period	$ (27,831)	$ (42,848)
Changes in operating working capital items:
Increase in accounts payable and accrued expenses	8,567	46,728
Increase in due to Parent		1,525
Decrease in due to related party		(5,405)
Net Cash Used in Operating Activities	(19,265)
Cash Flows from Investing Activities:
Net Cash Provided by Investing Activities
Cash Flows from Financing Activities:
Net Cash Provided by Financing Activities
Increase in Cash	(19,265)
Cash at beginning of period	19,265
Cash at end of period
Supplemental Disclosure of Interest and Income Taxes Paid:
Interest paid during the period
Income taxes paid during the period
Supplemental Disclosure of Non-cash Flow Investing and Financing Activities:
Cancellation of shares		1,663
Shares issued for debt		157,195
Forgiveness of debt		$ 130,000

Basis of Presentation, Backgrou

Basis of Presentation, Background and Description of Business	6 Months Ended
	Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation, Background and Description of Business	Note A - Basis of presentation, Background and Description of Business Basis of presentation The accompanying unaudited condensed financial statements of SMSA Crane Acquisition Corp. have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission, or the SEC, including the instructions to Form 10-Q and Regulation S-X. Certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted from these statements pursuant to such rules and regulations and, accordingly, they do not include all the information and notes necessary for comprehensive financial statements and should be read in conjunction with our audited financial statements for the year ended December 31, 2017, included in our Annual Report on Form 10-K for the year ended December 31, 2017. In the opinion of the management of the Company, all adjustments, which are of a normal recurring nature, necessary for a fair statement of the results for the six month period have been made. Results for the interim period presented are not necessarily indicative of the results that might be expected for the entire fiscal year. When used in these notes, the terms "Company", "we", "us" or "our" mean SMSA Crane Acquisition Corp. Background and Description of Business SMSA Crane Acquisition Corp. was organized on September 9, 2009 as a Nevada corporation to effect the reincorporation of Senior Management Services of Crane, Inc., a Texas corporation, mandated by the plan of reorganization discussed below. The Company's emergence from Chapter 11 of Title 11 of the United States Code on August 1, 2007 caused a change in majority ownership and voting control - that is, loss of control by the then-existing stockholders, a court-approved reorganization, and a reliable measure of the entity's fair value - resulting in a fresh start, creating, in substance, a new reporting entity. Accordingly, the Company, post-bankruptcy, had no significant assets, liabilities or operating activities. Therefore, the Company, as a new reporting entity, qualified as a shell company as defined in Rule 405 under the Securities Act of 1933, and Rule 12b-2 under the Securities Exchange Act of 1934. The Company's Plan of Reorganization (the "Plan") was confirmed by the United States Bankruptcy Court, Northern District of Texas – Dallas Division on August 1, 2007 and became effective on August 10, 2007. On November 5, 2010, the Company entered into a transaction with Carolyn C. Shelton as discussed in Note A and a Certificate of Compliance with certain bankruptcy confirmation provisions was issued by the Bankruptcy Court on November 10, 2010. On August 29, 2013, Coquí Radio Pharmaceuticals, Corp. ("Coquí") closed a transaction through which Coquí purchased 9,500,000 outstanding shares of common stock and agreed to purchase an additional 400,000 outstanding shares of common stock of the Company from existing shareholders in a private transaction in exchange for $280,000. The additional 400,000 shares were subsequently acquired on October 24, 2013 and Coquí became the majority controlling stockholder of the Company. The Company's business plan is now to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. The Company is not restricting its potential target companies to any specific business, industry or geographical location. No assurances can be given that the Company will be successful in locating or negotiating with any target company.

Change of Control

Change of Control	6 Months Ended
	Jun. 30, 2018
Change of Control [Abstract]
Change of Control	Note B - Change of Control Coqui the principal shareholder of the Company entered the Stock Purchase Agreement, effective as of the 26th day of June, 2017, with Irwin Eskanos (“Buyer”). Coqui agreed to sell to the Buyer, and the Buyer agreed to purchase from Coqui, a total of 9,947,490 shares of common stock of the Company for a total purchase price of $250,000. These purchased shares represented approximately 99.00% of the Company’s issued and outstanding shares of Common Stock. Also, concurrently with the sale of controlling interest, Coqui paid all outstanding liabilities of the Company as of the date of this sale. As a result, Coqui paid $130,000 of the Company’s outstanding accounts payable through the attorney’s escrow accounts and agreed to forgive all of its debts at the closing of this transaction. The Company recorded Coqui’s forgiveness of debt of $130,000 under Additional paid in capital, for the three and six months ended June 30, 2017. On June 26, 2017, the board of directors appointed Irwin Eskanos as our new sole Director, President, Secretary, Treasurer, CEO, and CFO. Following these appointments, the board accepted the resignation of Carmen I. Bigles as our former sole officer and director.

Going Concern

Going Concern	6 Months Ended
	Jun. 30, 2018
Going Concern [Abstract]
Going Concern	Note C – Going Concern We have incurred recurring losses since inception and expect to continue to incur losses as a result of legal and professional fees and our corporate general and administrative expenses. Our net losses incurred for the six months ended June 30, 2018 and 2017, amounted to approximately $28,000 and $43,000, respectively, and working capital (deficits) was approximately $(55,000) and $(27,000), respectively, at June 30, 2018 and December 31, 2017. As a result, there is substantial doubt about our ability to continue as a going concern. In the event that we are unable to generate sufficient cash from our operating activities or raise additional funds, we may be required to delay, reduce or severely curtail our operations or otherwise impede our on-going business efforts, which could have a material adverse effect on our business, operating results, financial condition and long-term prospects. The Company expects to seek to obtain additional funding through future equity issuances. There can be no assurance as to the availability or terms upon which such financing and capital might be available.

Summary of Significant Accounti

Summary of Significant Accounting Policies and Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies and Recent Accounting Pronouncements	Note D - Summary of Significant Accounting Policies and Recent Accounting Pronouncements Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the valuation of deferred tax assets. Actual results could differ from those estimates. Cash and cash equivalents The Company considers all cash on hand and in banks, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. Income taxes The Company files income tax returns in the United States of America and various states, as appropriate and applicable. The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. The Company has adopted the provisions of ASC 740-10 "Accounting for Uncertain Income Tax Positions". The Codification Topic requires the recognition of potential liabilities as a result of management's acceptance of potentially uncertain positions for income tax treatment on a "more-likely-than-not" probability of an assessment upon examination by a respective taxing authority. As a result of the implementation of Codification's Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits. Income (Loss) per share Basic earnings (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective period presented in our accompanying financial statements. Fully diluted earnings (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (consisting of outstanding warrants). Common stock equivalents represent the dilutive effect of the assumed exercise of outstanding stock warrants, the options or convertible securities, using if converted method, and only if the common stock equivalents are considered dilutive based upon the Company's net income (loss) position . As of June 30, 2018 and December 31, 2017, the Company had no outstanding stock warrants, options or convertible securities which could be considered dilutive for purposes of the loss per share calculation. Recently Adopted Accounting Pronouncements Management does not believe that any recently adopted or issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial statements. Income Taxes In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory ("ASU 2016-16"), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-06 will be effective for the Company in its first quarter of 2019. The Company is currently evaluating the impact of adopting ASU 2016-16 on its consolidated financial statements.

Fair Value of Financial Instrum

Fair Value of Financial Instruments and fair value measurements	6 Months Ended
	Jun. 30, 2018
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments and fair value measurements	Note E - Fair Value of Financial Instruments and fair value measurements The carrying amount of cash, accounts payable and accrued expenses and due to shareholder, approximates fair value due to the short term nature of these items and/or the current interest rates payable in relation to current market conditions. ASC Topic 820, "Fair Value Measurements and Disclosures," requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, "Financial Instruments," defines fair value, and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows: · Level 1: Observable inputs such as quoted prices in active markets; · Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and · Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Due to Shareholder

Due to Shareholder	6 Months Ended
	Jun. 30, 2018
Related Party Transactions [Abstract]
Due to Shareholder	Note F - Due to Shareholder As of June 30, 2018 and December 31, 2017, the Company owes $39,115 and $39,115, respectively, to Mr. Irwin Eskanos, the principal shareholder of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.

Concentration of Credit Risk

Concentration of Credit Risk	6 Months Ended
	Jun. 30, 2018
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	Note G - Concentration of Credit Risk At times cash deposited with financial institutions may exceed federally insured limits. The Company has not experienced any losses in such accounts through June 30, 2018.

Contingencies

Contingencies	6 Months Ended
	Jun. 30, 2018
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Note H - Contingencies The Company was contemplating a possible merger by the Company and Coquí. The Company's business plan is now to pursue a business combination through the acquisition of, or merger with, an existing company seeking the perceived advantages of being a publicly traded corporation. No assurances can be given that the Company will be successful in pursuing a business combination in the near future or at all.

Stockholders' Deficit

Stockholders' Deficit	6 Months Ended
	Jun. 30, 2018
Stockholders' Equity Note [Abstract]
Stockholders' Deficit	Note I - Stockholders' Deficit Pursuant to our Articles of Incorporation, our board has the authority, without further stockholder approval, to provide for the issuance of up to 10,000,000 shares of our preferred stock in one or more series and to determine the dividend rights, conversion rights, voting rights, rights in terms of redemption, liquidation preferences, the number of shares constituting any such series and the designation of such series. Our board has the power to afford preferences, powers and rights (including voting rights) to the holders of any preferred stock preferences, such rights and preferences being senior to the rights of holders of common stock. During January 2017 to March 2017, 48 shareholders of the Company, who previously acquired shares of the Company’s common stock, par value of $0.001 per share (the “SMSA Crane Shares”), in a private placement with the Company, at price of $3.31 per share, enter into an share exchange agreement with Coqui. The 48 investors agreed to exchange their SMSA Crane Shares for an equal value of shares of Coqui’s common stock, par value of $0.1 per share (the “Coqui Shares”), and Coqui agreed to proceed with the proposed share exchange. As a result, 1,663,443 SMSA Crane Shares outstanding held by these 48 shareholders and 51,300 outstanding warrants held by Pariter, the placement agent, were exchanged for Coqui Shares and warrants and the Company cancelled these SMSA Crane Shares and warrants. On May 16, 2017, the Board of Directors approved the issuance of 47,490 shares of its common shares to Coqui, based on the private placement share price of $3.31 in satisfaction for the total debt owed to Coqui of $157,195. On June 26, 2017, our former controlling shareholder, Coqui Radio Pharmaceuticals Corp. (“Coqui”), sold 9,947,490 shares of common stock to Irwin Eskanos for a purchase price of $250,000. See Note B – Changes of Control. There were no common shares issued or cancelled during the six months ended June 30, 2018. There were no preferred shares issued and outstanding at June 30, 2018 and December 31, 2017. There were 10,047,495 shares and 10,047,495 shares of common stock issued and outstanding with a par value of $0.001 as of June 30, 2018 and December 31, 2017, respectively.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2018
Subsequent Events [Abstract]
Subsequent Events	Note J - Subsequent Events In accordance with ASC 855-10, Company management reviewed all material events through the date of the issuance of these financial statements and determined that there are no additional material subsequent events to report, except as noted. During October 2019, the Company received a loan of $35,000 from Mr. Irwin Eskanos, the principal shareholder of the Company, for the funding of its current operating expenses. The amount owing is unsecured, non-interest bearing, and due on demand.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Policies)	6 Months Ended
	Jun. 30, 2018
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the valuation of deferred tax assets. Actual results could differ from those estimates.
Cash and cash equivalents	Cash and cash equivalents The Company considers all cash on hand and in banks, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.
Income taxes	Income taxes The Company files income tax returns in the United States of America and various states, as appropriate and applicable. The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, Income Taxes. The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax basis of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws. The Company records a valuation allowance to reduce deferred tax assets to the amount that is believed more likely than not to be realized. The Company has adopted the provisions of ASC 740-10 "Accounting for Uncertain Income Tax Positions". The Codification Topic requires the recognition of potential liabilities as a result of management's acceptance of potentially uncertain positions for income tax treatment on a "more-likely-than-not" probability of an assessment upon examination by a respective taxing authority. As a result of the implementation of Codification's Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits.
Income (Loss) per share	Income (Loss) per share Basic earnings (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective period presented in our accompanying financial statements. Fully diluted earnings (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (consisting of outstanding warrants). Common stock equivalents represent the dilutive effect of the assumed exercise of outstanding stock warrants, the options or convertible securities, using if converted method, and only if the common stock equivalents are considered dilutive based upon the Company's net income (loss) position . As of June 30, 2018 and December 31, 2017, the Company had no outstanding stock warrants, options or convertible securities which could be considered dilutive for purposes of the loss per share calculation.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements Income Taxes In October 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-16, Income Taxes (Topic 740): Intra-Entity Transfer of Assets Other than Inventory ("ASU 2016-16"), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. ASU 2016-06 will be effective for the Company in its first quarter of 2019. The Company is currently evaluating the impact of adopting ASU 2016-16 on its consolidated financial statements.

Basis of presentation, Backgr_2

Basis of presentation, Background and Description of Business (Details) - Coqui Radio Pharmaceuticals Corp [Member] - USD ($)	1 Months Ended		3 Months Ended
	Oct. 31, 2013	Aug. 31, 2013	Oct. 31, 2013
Related Party Transaction [Line Items]
Shares of common stock issued for cash	400,000	9,500,000
Proceeds from issuance of private placement			$ 280,000

Change of Control (Details)

Change of Control (Details) - USD ($)	Jun. 27, 2017	Jun. 26, 2017	Sep. 30, 2016	Jun. 30, 2018	Jun. 30, 2017
Change of Control [Abstract]
Number of shares sold to buyer of company	9,947,490	9,947,490
Total purchase price of shares sold to buyer of company	$ 250,000	$ 250,000
Percentage of outstanding shares sold to buyer in purchase of company	99.00%
Accounts payable paid by previous owner of company	$ 130,000
Forgiveness of debt recorded by company			$ 130,000		$ 130,000

Going Concern (Details)

Going Concern (Details) - USD ($)	3 Months Ended				6 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2017
Going Concern [Abstract]
Net Loss	$ 20,950	$ 6,881	$ 42,030	$ 818	$ 27,831	$ 42,848
Working capital deficits	$ (55,000)				$ (55,000)		$ (27,000)

Summary of Significant Accoun_3

Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2018	Dec. 31, 2017
Accounting Policies [Abstract]
Outstanding stock warrants, options or convertible securities which could be considered as dilutive for purposes of the loss per share calculation	0	0

Due to Shareholder (Details)

Due to Shareholder (Details) - USD ($)	Jun. 30, 2018	Dec. 31, 2017
Related Party Transactions [Abstract]
Due to shareholder	$ 39,115	$ 39,115

Stockholders' Deficit (Narrativ

Stockholders' Deficit (Narrative) (Details) - USD ($)	Jun. 27, 2017	Jun. 26, 2017	May 16, 2017	Mar. 31, 2017	Jun. 30, 2018	Dec. 31, 2017
Class of Stock [Line Items]
Preferred stock, shares authorized					10,000,000	10,000,000
Preferred stock, shares issued					0	0
Preferred stock, shares outstanding					0	0
Common stock, shares issued					10,047,495	10,047,495
Common stock, shares outstanding					10,047,495	10,047,495
Common stock, par value per share					$ 0.001	$ 0.001
Share price			$ 3.31
Shares of common stock exchanged and cancelled				1,663,443
Warrants cancelled				51,300
Debt exchanged for stock			$ 157,195
Debt exchanged for stock, shares			47,490
Number of shares sold to buyer of company	9,947,490	9,947,490
Total purchase price of shares sold to buyer of company	$ 250,000	$ 250,000
Coqui Radio Pharmaceuticals Corp [Member]
Class of Stock [Line Items]
Common stock, shares outstanding				0.1
Share price				$ 3.31

Subsequent Events (Narrative) (

Subsequent Events (Narrative) (Details)	1 Months Ended
	Oct. 31, 2019USD ($)
Subsequent Events [Abstract]
Proceeds from loan	$ 35,000